The Sahlgrenska Anti-VEGF Study

Clinical trial NCT04101877 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04101877
Sponsor: Vastra Gotaland Region
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Neovascular Age-related Macular Degeneration

Start date: 2020-09-03
Primary completion: 2026-10-01
Enrollment: 402

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.